The price of tofacitinib 11 mg can vary significantly depending on factors such as dosage form, strength, quantity, and pharmacy. Tofacitinib is a prescription medication used to treat rheumatoid arthritis, psoriatic arthritis, and ulcerative colitis.
How Much Does Tofacitinib 11 mg Cost?
Without insurance, a prescription for tofacitinib 11 mg can range from approximately $1,000 to over $2,000 for a 30-day supply [1]. Costs can fluctuate based on the specific product (e.g., immediate-release vs. extended-release formulations) and the dispensing pharmacy.
Can Insurance Cover Tofacitinib 11 mg?
Insurance coverage for tofacitinib 11 mg varies by plan. Many insurance providers may require prior authorization and may have specific criteria for coverage, such as previous treatment failures with other medications. Co-payment amounts will depend on the individual's insurance plan and whether the drug is on their formulary.
Are There Tofacitinib 11 mg Discount Programs?
Pharmaceutical manufacturers often provide patient assistance programs or savings cards that can help reduce the out-of-pocket cost for eligible patients [2]. These programs can offer significant discounts on prescription medications like tofacitinib.
What Are the Generic Alternatives for Tofacitinib 11 mg?
As of late 2023, generic versions of tofacitinib are available. The introduction of generics typically leads to a reduction in overall drug prices, though specific pricing for generic tofacitinib 11 mg will vary. Information on patent expiries and generic availability can be found on resources like DrugPatentWatch.com [3].
What Are the Risks Associated with Tofacitinib 11 mg?
Tofacitinib carries several significant safety warnings, including increased risk of serious infections, blood clots, stroke, heart attack, and certain cancers. Patients should discuss these risks thoroughly with their healthcare provider before starting treatment [4].
How Does Tofacitinib 11 mg Work?
Tofacitinib is a Janus kinase (JAK) inhibitor. It works by blocking the activity of certain enzymes in the body that are involved in inflammation [5]. By reducing this inflammation, it helps to manage the symptoms of autoimmune diseases.
Who Manufactures Tofacitinib?
Tofacitinib is manufactured by Pfizer and is marketed under the brand name Xeljanz® [6].
---
Sources:
1. https://www.goodrx.com/tofacitinib
2. https://www.pfizerpro.com/our-products/xeljanz/patient-support
3. https://drugpatentwatch.com/
4. https://www.fda.gov/drugs/drug-safety-and-availability/fda-drug-safety-label-changes-including-black-box-warnings-issued-january-2019
5. https://www.xeljanz.com/
6. https://www.pfizer.com/